XRAY DENTSPLY SIRONA Inc.

INVESTOR ALERT: Investigation of Dentsply Sirona Announced by Holzer & Holzer

Holzer & Holzer, LLC is investigating whether Dentsply Sirona, Inc. (“Dentsply” or the “Company”) (NASDAQ: XRAY) complied with the federal securities laws. On September 29, 2017, Dentsply reported more than a billion dollar loss for its second quarter, which was followed by the resignation of its top executive officers. Dentsply also has disclosed that it is cooperating with a Securities and Exchange Commission investigation into its accounting practices.

If you purchased Dentsply common stock and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer Esq. at [email protected] or Marshall P. Dees, Esq. at [email protected], or call the firm by toll-free telephone at (888) 508-6832.

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.

EN
04/10/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DENTSPLY SIRONA Inc.

Dentsply Sirona Inc: 2 directors

Two Directors at Dentsply Sirona Inc bought/maiden bought 55,000 shares at between 13.469USD and 14.148USD. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company'...

 PRESS RELEASE

Dentsply Sirona to Participate in the Leerink Partners Global Healthca...

Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2026 CHARLOTTE, N.C., March 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Leerink Partners Global Healthcare Conference. Management is scheduled to present on Tuesday, March 10, 2026, at 10:00 a.m. EST. Investors and other interested parties will be able to access a live audio webcast and an audio webcast replay by visiting the Investors section of the Dentsply Sirona website at About Dentspl...

 PRESS RELEASE

Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Pro...

Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook News Summary Q4 2025 net sales of $961 million increased 6.2%, constant currency sales increased 2.5%Q4 2025 reported net loss of ($146) million and diluted loss per share of ($0.74) driven by goodwill and intangible impairments of ($144) million, net of taxQ4 2025 adjusted EPS of $0.27FY 2026 outlook: net sales in the range of $3.5B to $3.6B; adjusted EPS of $1.40 to $1.50(1)Announced a restructuring initiative to redirect approximately $120 million annually into the Return-to-Growth Action ...

 PRESS RELEASE

Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Dir...

Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors New directors bring decades of financial leadership and board experience to enhance strategic oversight of Return-to-Growth action plan and long-term value creation CHARLOTTE, N.C., Feb. 24, 2026 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced the appointments of James (Jim) D. Forbes and Brian P. McKeon to its Board of Directors (the “Board”), effective February 27, 2026. Mr. Forbes is a veteran healthcare investment banker with 30 years of experie...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch